Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-67.85M
↑ 40% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-112.79M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-67.85M | +62.3% |
| 2024 | $-179.81M | -10.7% |
| 2023 | $-162.37M | -80.1% |
| 2022 | $-90.18M | -2.2% |
| 2021 | $-88.24M | +38.3% |
| 2020 | $-143.06M | -225.8% |
| 2019 | $113.74M | +176.5% |
| 2018 | $-148.70M | +19.9% |
| 2017 | $-185.62M | -5.6% |
| 2016 | $-175.86M | - |